For 9 months AstraZeneca has had the sales of its blockbuster heartburn drug Nexium protected by a bureaucratic dam that has kept generics from getting to market. But the agency opened the ...

Nexium and its generic versions had a market of approximately $70 million for ... 20 mg and 40 mg. Cipla is the first company to file for ... Cipla's product is the generic of AstraZeneca’s Nexium.

AstraZeneca, Ranbaxy settle Nexium patent dispute. By Reuters. April 16, 2008 7:05 AM UTC Updated ago By Ben Hirschler ... and the 40 mg version of ulcer pill Prilosec, ...

Shares in AstraZeneca jump nearly 11% after the drugmaker announces it has settled a patent infringement case with Ranbaxy Laboratories over its Nexium ulcer drug.

After nearly 15 years on the market, AstraZeneca’s popular “purple pill,” Nexium, will face generic competition. Teva Pharmaceuticals, an Israeli generics manufacturer with American headquarters in ...

Esomeprazole (Nexium) Aside from the "Es" in the second compound, the names are identical, which makes perfect sense, since the two drugs are essentially the same. But there is one tiny (and usually ...

Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec.

AstraZeneca has launched Nexium Direct, a program that provides patients with the option of having the British pharma's purple pill for acid reflux disease delivered directly to their homes.

The FDA said this morning that it's looking at the safety of AstraZeneca's heartburn drug Nexium and its kissing cousing Prilosec. The regulators said in pretty clear terms that the review isn't ...